These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15969)

  • 41. Beta-adrenoceptor blocking drugs.
    Prichard BN
    Practitioner; 1977 Oct; 219(1312):501-8. PubMed ID: 22852
    [No Abstract]   [Full Text] [Related]  

  • 42. Weathering the storm: beta-blockade and the potential for disaster in severe hyperthyroidism.
    Fraser T; Green D
    Emerg Med (Fremantle); 2001 Sep; 13(3):376-80. PubMed ID: 11554873
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical manifestations of hyperthyroidism after treatment with selective beta 1 adrenoceptor blocking agents.
    Shikara MM; Polena S; Solinas A; Sanghvi K; Gintautas J
    Proc West Pharmacol Soc; 2003; 46():125-6. PubMed ID: 14699906
    [No Abstract]   [Full Text] [Related]  

  • 44. [Studies on the mechanism of action of sulfonylurea compounds. Effect of glibornuride and insulin on blood sugar, plasma catecholamines and on the immunologically determinable insulin following blockade of adrenergic receptors].
    Cordes U; Beyer J; Sell G; Haupt E; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2164. PubMed ID: 4146790
    [No Abstract]   [Full Text] [Related]  

  • 45. [Effects of alpha-and beta-adrenoceptor blocking agent (YM-09538) upon the clinical features of a patient with pheochromocytoma].
    Matsuura H; Koyama S; Tsuchioka Y; Yoshida M; Kurogane H
    Horumon To Rinsho; 1982 Dec; 30(12):1439-46. PubMed ID: 6130862
    [No Abstract]   [Full Text] [Related]  

  • 46. The effect of chronic adrenergic blockade on the inhibition by epinephrine of growth hormone and insulin release in sheep.
    Hertelendy F; Takahashi K; Machlin LJ; Kipnis DM
    Horm Metab Res; 1970 Sep; 2(5):257-9. PubMed ID: 4400839
    [No Abstract]   [Full Text] [Related]  

  • 47. Adrenergic modulation of pancreatic A, B, and D cells alpha-Adrenergic suppression and beta-adrenergic stimulation of somatostatin secretion, alpha-adrenergic stimulation of glucagon secretion in the perfused dog pancreas.
    Samols E; Weir GC
    J Clin Invest; 1979 Feb; 63(2):230-8. PubMed ID: 34627
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Hyperthyroidism in type 1 diabetics].
    Schröder H
    Med Monatsschr Pharm; 2004 Jan; 27(1):21-2. PubMed ID: 14752929
    [No Abstract]   [Full Text] [Related]  

  • 49. Beta-receptor antagonists.
    Lancet; 1970 Jun; 1(7661):1380. PubMed ID: 4194133
    [No Abstract]   [Full Text] [Related]  

  • 50. Adrenergic beta receptor inhibition and hyperthyroidism.
    Malcolm J
    Acta Cardiol; 1972; ():Suppl 15:307-2. PubMed ID: 4147614
    [No Abstract]   [Full Text] [Related]  

  • 51. Editorial: The pharmacology and therapeutic use of beta-adrenergic receptor blocking drugs in cardiovascular disease.
    Harrison DC
    Drugs; 1974; 7(1):1-7. PubMed ID: 4152164
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of adrenergic blockade on the release of insulin, glucagon and somatostatin from the pancreas in response to splanchnic nerve stimulation in cats.
    Andersson PO; Holst J; Järhult J
    Acta Physiol Scand; 1982 Dec; 116(4):403-9. PubMed ID: 6133409
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [In-vivo study of beta-adrenergic stimulating or blocking agents on insulin secretion. Pharmacological differentiation of the type of beta receptor involved].
    Mariani M; Loubatières A; Sorel G; Savi L
    Diabete; 1971; 19(3):129-33. PubMed ID: 4400313
    [No Abstract]   [Full Text] [Related]  

  • 54. [Effect of adrenergic blockade by trimepranol and propranolol on protein iodine and the severity of thyrotoxicosis].
    Felt V; Vána S; Zamrazil V
    Cas Lek Cesk; 1971 Jun; 110(25):595-7. PubMed ID: 4103498
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effect of beta receptor blockaders on hyperthyroidism].
    Földes J; Bános C; Borvendég J; Gyertyánfy G
    Orv Hetil; 1979 May; 120(18):1080-2. PubMed ID: 35773
    [No Abstract]   [Full Text] [Related]  

  • 56. [Effects of trimepranol and propranolol in thyreotoxicosis and in patients with arrhythmia].
    Vána S; Felt V; Nĕmec J; Zamrazil V
    Cas Lek Cesk; 1972 Jun; 111(20):454-9. PubMed ID: 4402995
    [No Abstract]   [Full Text] [Related]  

  • 57. Abolition of dopaminergic insulin secretion by beta-adrenergic antagonism.
    Cyrus J; Stagner J; Samols E
    Endocrinology; 1982 Jul; 111(1):214-8. PubMed ID: 6123430
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Secondary forms of diabetes mellitus associated with endocrine diseases].
    Borges-Martins L; Betea D; Daly A; Beckers A
    Rev Med Liege; 2005; 60(5-6):442-7. PubMed ID: 16035309
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pharmacological study of the role of beta-adrenergic receptors in insulin secretion in the dog].
    Loubatières A; Mariani MM; Savi L; Sorel G
    C R Seances Soc Biol Fil; 1970; 164(3):632-6. PubMed ID: 4395605
    [No Abstract]   [Full Text] [Related]  

  • 60. Beta-adrenergic receptor blocking drugs in hyperthyroidism.
    Turner P
    Drugs; 1974; 7(1):48-54. PubMed ID: 4134125
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.